| BaytrilŪ Antibacterial Injectable Solution |
Please note that the US Code of Federal Regulations (21 CFR version April 1, 2000) is the official source of regulatory information concerning approved animal drug products.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Tradename(s) | BaytrilŪ Antibacterial Injectable Solution |
| Sponsor | Bayer Corp., Agriculture Division, Animal Health |
| Ingredient(s) | Enrofloxacin |
| Species | Dog, no use class stated or implied |
| Route(s) | Intramuscular |
| DoseForm(s) | Liquid |
| 522.812 Enrofloxacin solution.
Specifications: Each milliliter of sterile aqueous solution contains 22.7 milligrams of enrofloxacin. Conditions of use: Dogs Amount: 2.5 milligrams intramuscularly per kilogram (1.13 milligrams per pound) of body weight as an initial dose only. Indications: Dogs for management of diseases associated with bacteria susceptible to enrofloxacin. Limitations: As a single, intramuscular, initial dose followed by use of tablets twice daily for 2 to 3 days beyond cessation of clinical signs to a maximum of 10 days. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |
||||